Precigen’s first FDA-approved RRP drug starts selling as access expands $100.4M cash is expected to fund operations to cash flow break-even. CMS assigned PAPZIMEOS a permanent J-code effective April 1, 2026.

#PGEN Precigen Reports Full Year 2025 Financial Results and Business Updates

www.stocktitan.net/news/PGEN/precigen-repor...

Biotech firm Precigen schedules March 25 call on 2025 results Investors get full year 2025 results and business updates on Precigen’s March 25 call at 4:30 PM ET. See how to access the webcast and dial in.

#PGEN Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

www.stocktitan.net/news/PGEN/precigen-to-an...

$PGEN Soars on FDA Approval of PAPZIMEOS for RRP Treatment!
Precigen surges after historic approval of its first-in-class RRP therapy
#PGEN #BiotechStocks #FDAApproved

https://a777.lt/73YoM7

Leading Indicators, Wednesday January 7, 2026 – Crystal Equity Research

Small-cap stocks in new uptrend according to average directional index, Wed Jan 7th - #QUIK #SDA #WLDN #ZNTL #AEVA #BACQ #DTI #ESQ #HYFT #ICHR #LUCD #NVAX #PGEN #SB #OGN #NSP #LPG #IHD #FC #EBS #CYD #BKSY - More: crystalequityresearch.com/leading-indi... - #smallcap

GameGaz Daily 2025.12.31 メモリ価格上昇で次世代機発売延期も,Switch 2開発機不足解消,PlayStation Vueの脆弱性,PSV Cleaner 1.10,RocketVideoPlayer v2.1.1,Vid2RVID v1.5.1,WiiLink Mail Patcher (Mail-Patcher) v2.2.1,shadPS4 Pre-release-shadPS4-2025-12-30-954cc77,pEMU v7.1(pFBNEO / pGBA/ pGEN / pNES/ pSNES 7.1),MAME 0.284→→→この記事の続きを読む The post GameGaz Daily 2025.12.31 first appeared on 大人のためのゲーム講座.

Most Searched, Monday December 22, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Dec 22nd - #ZIM #PLUG #TE #CMCT #MENS #FJET #AZI #RZLV #CETX #DNN #RXRX #VEDU #SIDU #RDW #PLG #PGEN #MGUY #IPI #HYMC #ABQQD - More: crystalequityresearch.com/most-searche... - #smallcap

Most Searched, Tuesday December 16, 2025 – Crystal Equity Research

Most searched small-cap stocks, Tue Dec 16th - #BEAT #ONDS #RZLV #WRD #VFF #TLRY #RAMP #PLUG #PGEN #PEBO #NNOX #MGNX #LUNR #DAWN #CNDT #CAAS #BORR #RILY #AMCI #ALLO - More: crystalequityresearch.com/most-searche... - #smallcap

Leading Indicators, Thursday September 25, 2025 – Crystal Equity Research

Small-cap stocks with declining money flow, Thu Sept 25th - #MTNB #DSS #ZYXI #UNIT #TRUE #SCVL #PGEN #OSS #NBN #INKT #DYN #CAC #BASE #ACB #USNA #SFL #PHR #NLOP #LUXE #HE #BAK #ACCO - More: crystalequityresearch.com/leading-indi... - #smallcap

#PGEN #AZN #MLYS #082d9db2-09a3-4de9-8906-575b6bed1a96 #investing

Origin | Interest | Match

$125M Non-Dilutive Deal: Precigen Secures Major Funding for Revolutionary HPV Immunotherapy Launch Biotech firm Precigen partners with Pharmakon for $125M credit facility, with $100M funded upfront. Financing supports PAPZIMEOS commercialization, international expansion, and pediatric indication development.

#PGEN Precigen Announces Up to $125 Million Non-Dilutive Financing

www.stocktitan.net/news/PGEN/precigen-annou...

JUST IN: ( NASDAQ: #PGEN ) Biotech & Solar Blaze Into the Close: After-Hours Watchlist Heats Up

JUST IN: ( NASDAQ: #PGEN ) Quarterly Surge and FDA Milestones

Just In: ( NASDAQ: #PGEN ) Precigen Secures Historic FDA Approval for PAPZIMEOS- First and Only Therapy for Adult RRP Patients

Breaking News: ( NASDAQ: #PGEN ) Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Breakthrough RRP Treatment PRGN-2012 Nears FDA Decision with 51% Complete Response Rate First-in-class RRP therapy shows promising 51% complete response rate in trials. FDA decision expected August 2025. See latest clinical data and launch readiness updates.

#PGEN Precigen Reports First Quarter 2025 Financial Results and Business Updates

www.stocktitan.net/news/PGEN/precigen-repor...

Precigen's Breakthrough RRP Treatment Achieves 51% Complete Response, FDA Decision by August Precigen's PRGN-2012 could become first FDA-approved RRP treatment, showing 51% complete response rate. Company secures $87.5M funding, extending runway through potential 2025 launch.

#PGEN Precigen Reports Full Year 2024 Financial Results and Business Updates

www.stocktitan.net/news/PGEN/precigen-repor...

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#HP, #WEN, #PGEN, #MGY, #TME

#OptionFlow #OptionsTrading #Trading

Precigen Gene Therapy Pioneer Reveals 2024 Performance: Key Financial Results Coming March 19 Join Precigen's earnings call on March 19 at 4:30 PM ET. Leading gene therapy developer to discuss 2024 performance and pipeline updates in immuno-oncology and autoimmune treatments.

#PGEN Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th

www.stocktitan.net/news/PGEN/precigen-to-an...

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#PSN, #TRIP, #PGEN, #VIAV, #TSEM

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #PSN 10.6x
2. #TRIP 6.3x
3. #PGEN 5.6x
4. #ASTS 3.5x
5. #SONY 2.4x

#OptionFlow #OptionsTrading #Trading

Precigen Submits FDA Application for Breakthrough RRP Treatment with 50% Complete Response Rate Precigen completes BLA submission for PRGN-2012, showing remarkable 50% complete response in RRP patients and 85% reduction in surgeries. FDA breakthrough therapy awaits review.

#PGEN Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis

www.stocktitan.net/news/PGEN/precigen-compl...

Precigen (PGEN) Secures $79M Strategic Financing, Extends Runway to 2026 for PRGN-2012 Launch Biotech firm Precigen raises $79M through preferred stock offering backed by notable investors, strengthening its position for PRGN-2012 commercialization in 2025.

#PGEN Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

www.stocktitan.net/news/PGEN/precigen-annou...

#PGEN Precigen Reports Third Quarter 2024 Financial Results and Business Updates

www.stocktitan.net/news/PGEN/precigen-repor...